Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier.
Yellow fever vaccine-associated neurotropic disease (YEL-AND) - A case report.
Management of bladder dysfnction in patients with multiple sclerosis.
Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
RAGE-ligand axis: A new biomarker in multiple sclerosis, time for multicentre validation study!
Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies.
Estimating epidemiological data of Multiple sclerosis using hospitalized data in Shandong Province, China.
CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis.
From Natural Product to the First Oral Treatment for Multiple Sclerosis: The Discovery of FTY720 (Gilenya™)?
2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency suppresses central nervous system damage in a murine MOG-induced multiple sclerosis model.
Screening and characterization of molecules that modulate the biological activity of IFNs-I.
Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells.
Adipose-Derived Stem Cells Enhance Axonal Regeneration through Cross-Facial Nerve Grafting in a Rat Model of Facial Paralysis.
Imaging of noninfectious inflammatory disorders of the spinal cord.
Proteomics and transcriptomics of peripheral nerve tissue and cells unravel new aspects of the human schwann cell repair phenotype.
Multiple sclerosis: Biomarkers and genetic variants reflect disease course in multiple sclerosis.
"Gadolinium-Phobia:" Not a Helpful "Criterion" for Indication for Gadolinium-based Contrast Agent Administration in Multiple Sclerosis.
Delayed iron deposit and atrophy of the putamen in a case with osmotic demyelination syndrome.
Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.
Response on Paraparetic Guillain-Barré syndrome: non-demyelinating reversible conduction failure restricted to the lower limbs.
Astrocyte Dysfunction in Developmental Neurometabolic Diseases.
Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy.
Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G.
A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors.
γδ T Cells and NK Cells - Distinct Pathogenic Roles as Innate-Like Immune Cells in CNS Autoimmunity.

Pages